High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study.

Autor: de Resende Guimarães MFB; Serviço de Reumatologia, Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Rua Adolfo Pereira, 262, apto 901, Belo Horizonte, MG, 30310-350, Brazil. mfbresende@yahoo.com.br., Rodrigues CEM; Programa de Pós-graduacão em Ciȇncias Médicas, Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil., Gomes KWP; Universidade de Fortalea e Hospital Geral de Fortaleza-HGF, Fortaleza, Brazil., Machado CJ; Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil., Brenol CV; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Alegre, Brazil., Krampe SF; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Alegre, Brazil., de Andrade NPB; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Alegre, Brazil., Kakehasi AM; Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Jazyk: angličtina
Zdroj: Advances in rheumatology (London, England) [Adv Rheumatol] 2019 Oct 16; Vol. 59 (1), pp. 44. Date of Electronic Publication: 2019 Oct 16.
DOI: 10.1186/s42358-019-0089-1
Abstrakt: Introduction: Rheumatoid arthritis (RA) is a well-documented independent risk factor for cardiovascular disease. Obesity may provide an additional link between inflammation and accelerated atherosclerosis in RA.
Objective: To evaluate the association between obesity and disease parameters and cardiovascular risk factors in RA patients.
Method: Cross-sectional study of a cohort of RA patients from three Brazilian teaching hospitals. Information on demographics, clinical parameters and the presence of cardiovascular risk factors was collected. Blood pressure, weight, height and waist circumference (WC) were measured during the first consultation. Laboratory data were retrieved from medical records. Obesity was defined according to the NCEP/ATPIII and IDF guidelines. The prevalence of obesity was determined cross-sectionally. Disease activity was evaluated using the DAS28 system (remission < 2.6; low 2.6-3.1; moderate 3.2-5.0; high > 5.1).
Results: The sample consisted of 791 RA patients aged 54.7 ± 12.0 years, of whom 86.9% were women and 59.9% were Caucasian. The mean disease duration was 12.8 ± 8.9 years. Three quarters were rheumatoid factor-positive, the mean body mass index (BMI) was 27.1 ± 4.9, and the mean WC was 93.5 ± 12.5 cm. The observed risk factors included dyslipidemia (34.3%), type-2 diabetes (15%), hypertension (49.2%) and family history of premature cardiovascular disease (16.5%). BMI-defined obesity was highly prevalent (26.9%) and associated with age, hypertension and dyslipidemia. Increased WC was associated with diabetes, hypertension, dyslipidemia and disease activity.
Conclusion: Obesity was highly prevalent in RA patients and associated with disease activity.
Databáze: MEDLINE
Externí odkaz: